A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin
Crossref DOI link: https://doi.org/10.1186/s12941-016-0140-6
Published Online: 2016-04-12
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Thabit, Abrar K.
Alam, M. Jahangir
Khaleduzzaman, Mohammed
Garey, Kevin W.
Nicolau, David P.